What is the maximum infusion rate of hypertonic saline (sodium chloride) solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

The maximum infusion rate of hypertonic saline solution should not exceed 1-2 mL/kg/hour, with a maximum of 100 mL/hour in adults, to avoid rapid increases in serum sodium and the risk of osmotic demyelination syndrome, as recommended by the most recent guidelines 1.

Key Considerations

  • The concentration of hypertonic saline and the clinical scenario dictate the maximum infusion rate.
  • For 3% hypertonic saline, the recommended rate is typically 1-2 mL/kg/hour, not exceeding 100 mL/hour in adults for symptomatic hyponatremia.
  • Severe cases with neurological symptoms may require an initial bolus of 100-150 mL of 3% saline over 10-20 minutes, followed by continuous infusion.
  • The goal is to raise serum sodium by no more than 8-10 mEq/L in 24 hours to avoid osmotic demyelination syndrome, as supported by recent studies 1.

Administration Guidelines

  • Frequent monitoring of serum sodium (every 2-4 hours initially), neurological status, and fluid balance is essential during administration.
  • Hypertonic saline works by creating an osmotic gradient that pulls water from intracellular to extracellular spaces, reducing cerebral edema and increasing serum sodium concentration.
  • The use of hypertonic saline should be reserved for severely symptomatic acute hyponatremia, especially if a transplant is imminent, as recommended by recent guidelines 1.

Concentration-Specific Administration

  • For 7.5% or 23.4% concentrations used in severe traumatic brain injury or cerebral edema, administration should be slower, typically 250 mL of 7.5% over 30-60 minutes or 30 mL of 23.4% over 10-20 minutes.
  • The maximum serum osmolality in an individual patient was 431 mOsm.l-1, as reported in a study on pediatric head injury 2.

From the FDA Drug Label

Sodium Chloride Injection, USP, 23. 4% is hypertonic and must be diluted prior to administration. The maximum infusion rate of hypertonic saline (sodium chloride) solution is not explicitly stated in the provided drug label. Key points:

  • The label states that the solution is hypertonic and must be diluted prior to administration.
  • There is no information on the maximum infusion rate. 3

From the Research

Maximum Infusion Rate of Hypertonic Saline

  • The maximum infusion rate of hypertonic saline (sodium chloride) solution is not explicitly stated in the provided studies 4, 5, 6, 7, 8.
  • However, the studies suggest that hypertonic saline should be used with caution and in specific situations, such as in patients with significant neurologic symptoms or severe hyponatremia 4, 5, 6, 7, 8.
  • The European guidelines recommend bolus-wise administration of 150 mL of 3% hypertonic saline, but this recommendation is based on a low level of evidence 8.
  • One study suggests that reducing bolus-volume and reevaluating before repeating bolus infusion might prevent overcorrection 8.
  • Another study proposes specific infusion rates for 3% hypertonic saline solution, but the exact rates are not specified in the provided text 5, 7.

Key Considerations

  • The increase in serum sodium should not exceed 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome (ODS) 4, 8.
  • The treatment target is defined as an increase in serum sodium by 5-10 mEq/L within the first 24 hours and a maximum of 8 mEq/L during subsequent 24 hours 8.
  • Diuresis should be monitored, as symptoms caused by hypovolemia can be misinterpreted as severely symptomatic hyponatremia 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.